Compare AXGN & CLOV Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
| Metric | AXGN | CLOV |
|---|---|---|
| Founded | N/A | 2014 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Biotechnology: Electromedical & Electrotherapeutic Apparatus | Medical Specialities |
| Sector | Health Care | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 2.6B | 2.2B |
| IPO Year | 2013 | 2020 |
| Metric | AXGN | CLOV |
|---|---|---|
| Price | $48.18 | $4.27 |
| Analyst Decision | Strong Buy | Buy |
| Analyst Count | 9 | 3 |
| Target Price | ★ $42.33 | $2.90 |
| AVG Volume (30 Days) | 776.6K | ★ 4.1M |
| Earning Date | 04-28-2026 | 05-06-2026 |
| Dividend Yield | N/A | N/A |
| EPS Growth | N/A | ★ 38.03 |
| EPS | N/A | ★ 0.10 |
| Revenue | $225,208,000.00 | ★ $1,924,308,000.00 |
| Revenue This Year | $20.57 | $52.59 |
| Revenue Next Year | $16.68 | $15.37 |
| P/E Ratio | ★ N/A | $42.50 |
| Revenue Growth | 20.21 | ★ 40.34 |
| 52 Week Low | $15.27 | $1.58 |
| 52 Week High | $52.91 | $5.59 |
| Indicator | AXGN | CLOV |
|---|---|---|
| Relative Strength Index (RSI) | 49.18 | 47.24 |
| Support Level | $29.48 | $4.09 |
| Resistance Level | $52.91 | $5.19 |
| Average True Range (ATR) | 2.30 | 0.17 |
| MACD | -0.40 | 0.01 |
| Stochastic Oscillator | 30.89 | 40.19 |
Axogen Inc is engaged in the science, development, and commercialization of technologies for peripheral nerve regeneration and repair. The company provides clinically and economically effective repair solutions for surgeons and health care providers. Its products include Avance Nerve Graft, Axoguard Nerve Connector, Axoguard Nerve Protector, Axoguard Nerve Cap, and Avive Soft Tissue Membrane. It also offers an Axotouch Two-Point Discriminator used to measure the innervation density of any surface area of the skin. Its products are available in the United States, Canada, Germany, the United Kingdom, Spain, and several other countries.
Clover Health Investments Corp is a healthcare technology company. It focuses on empowering Medicare physicians to proactively manage chronic diseases through its proprietary software platform, Clover Assistant. This cloud-based solution provides personalized insights to physicians, enabling early detection and management of chronic conditions. It operates in one segment: Insurance, through which it offers PPO and HMO plans to Medicare Advantage members in several states.